TMO - Eli Lilly Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts | Benzinga
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Here's a look at some of the top health care stocks from several analysts, according to Benzinga Analyst Stock Ratings.
Eli Lilly and Company (NYSE: LLY)
- Citigroup analyst Andrew Baum maintained a Buy rating on the stock and boosted the price target from $525 to $675 on Oct. 23, 2023. This analyst sees around 16% upside in the stock and has an accuracy rate of 71%.
- Argus Research analyst David Toung maintained a Buy rating and increased the ...